Rankings
▼
Calendar
CORT FY 2025 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena
CORT
Corcept Therapeutics Incorporated
$4B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$761M
+12.8% YoY
Gross Profit
$748M
98.3% margin
Operating Income
$45M
5.9% margin
Net Income
$100M
13.1% margin
EPS (Diluted)
$0.82
Cash Flow
Operating Cash Flow
$142M
Free Cash Flow
$142M
Stock-Based Comp.
$85M
Balance Sheet
Total Assets
$837M
Total Liabilities
$189M
Stockholders' Equity
$648M
Cash & Equivalents
$120M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$761M
$675M
+12.8%
Gross Profit
$748M
$664M
+12.7%
Operating Income
$45M
$137M
-67.3%
Net Income
$100M
$140M
-28.7%
← Q4 2024
All Quarters
Q1 2025 →